Organization

The sector is organized as a consortium of 18 partners with a matrix organization between the selected pathologies and the technological platforms.

A matrix organization

Technology platforms

  • Medical Oncology
  • in vitro cell lines and bioassays
  • in vivo models
  • in vivo pharmacology
  • Anatomo-pathology
  • Genomic analyses – sequencing , NGS…
  • Human and mouse microbiome analyses – Metasequencing
  • Biobanking
  • Data base
  • Data mining
CarteAlpha-2016

Pathologies of interest

  • Colorectal cancer
  • Prostate cancer
  • Lung cancer
  • Breast cancer
  • Ovary cancer
  • Liver cancer
  • Pancreas Cancer
  • Lymphoma
  • Myeloma
  • Leukemia

Our Partners

SMEs

Ariana

Biofortis

biofortis-small

CTI-Biotech

Modul-Bio

Oncodesign

Oncomedics

 

Pharmaceutical companies

Ipsen

Pierre Fabre

Sanofi

Servier


Academic partners

Inserm

CNRS

logo-cnrsSmall

Université de Strasbourg

CHU de Toulouse

Centre Léon Bérard, Lyon

Synergie Lyon Cancer

Centre G-F Leclerc, Dijon

AP-HP


Institutional partners

BPI France

Investissements d'Avenir

Medicen

Alsace Biovalley

Lyonbiopôle

Cancer-Bio-Santé

logo-instit-cancer-biosante

Atlanpole Biotherapies

Partnership

Partenariat IMODI
IMODI is an open consortium integrated medical and technological innovation, by synergizing the expertises of its members

  • You have a know-how or an innovative technology that could benefits from the IMODI members expertise for its development/validation
  • You have original tools or cancer models that could complement the actual IMODI platforms
  • You have a research project that could be performed in collaboration with IMODI members
  • You want to access the IMODI scientific or commercial network visibility
  • You want to support the IMODI actions